Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Equity (2016 - 2025)

Iovance Biotherapeutics has reported Return on Equity over the past 9 years, most recently at 0.56% for Q4 2025.

  • Quarterly results put Return on Equity at 0.56% for Q4 2025, down 6.0% from a year ago — trailing twelve months through Dec 2025 was 0.56% (down 6.0% YoY), and the annual figure for FY2025 was 0.55%, up 2.0%.
  • Return on Equity for Q4 2025 was 0.56% at Iovance Biotherapeutics, up from 0.57% in the prior quarter.
  • Over the last five years, Return on Equity for IOVA hit a ceiling of 0.47% in Q1 2023 and a floor of 0.71% in Q1 2024.
  • Median Return on Equity over the past 3 years was 0.55% (2025), compared with a mean of 0.57%.
  • Peak annual rise in Return on Equity hit 20bps in 2024, while the deepest fall reached -24bps in 2024.
  • Iovance Biotherapeutics' Return on Equity stood at 0.71% in 2023, then grew by 29bps to 0.5% in 2024, then dropped by -11bps to 0.56% in 2025.
  • The last three reported values for Return on Equity were 0.56% (Q4 2025), 0.57% (Q3 2025), and 0.53% (Q2 2025) per Business Quant data.